Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 354,500
-6,000 (-1.66%)
At close: Oct 2, 2025
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 4.50 trillion as of October 6, 2025. Its market cap has increased by 20.78% in one year.
Market Cap
4.50T
Enterprise Value
4.90T
Revenue
1.47T
Ranking
n/a
PE Ratio
41.88
Stock Price
354,500.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 4.50T, an increase of 560.37%. That is a compound annual growth rate of 13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 4,495.14B | 26.38% |
| Dec 30, 2024 | 3,556.80B | -20.49% |
| Dec 28, 2023 | 4,473.42B | 20.54% |
| Dec 29, 2022 | 3,711.17B | 10.00% |
| Dec 30, 2021 | 3,373.87B | -23.27% |
| Dec 30, 2020 | 4,397.24B | 25.97% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |